A dermatologist guide to immunogenicity

Dermatologists should be aware that autoantibody formation may occur after the initiation of biologic therapy. This phenomenon has been referred to as immunogenicity and biologic fatigue. Because of this, patients may experience loss of clinical efficacy to a particular drug. To combat this phenomen...

Full description

Bibliographic Details
Main Authors: Collin M. Blattner, DO, Soham P. Chaudhari, DO, John Young, III, MD, Jenny E. Murase, MD
Format: Article
Language:English
Published: Wolters Kluwer 2016-09-01
Series:International Journal of Women's Dermatology
Online Access:http://www.sciencedirect.com/science/article/pii/S2352647516300089